Liste des médicaments et vaccins
| DESIGNATION | DCI | TITULAIRE AMM | PAYS D'ORIGINE | PGHT(FCFA) | N°AMM | DATE EXPIRATION AMM |
|---|---|---|---|---|---|---|
| DEPOFEM 150mg/mL Suspension injectable en flacon B/20 | MEDROXYPROGESTERONE | INCEPTA PHARMACEUTICALS LTD | Bangladesh | 11997.45 | AMM_2022_13460 | 2027-07-31 |
| DOLUTEGRAVIR/LAMIVUDINE/TENOFOVIR 50mg+300mg+300mg Comprimé B/30 | DOLUTEGRAVIR + LAMIVUDINE + TENOFOVIR | CIPLA QUALITY CHEMICAL INDUSTRIES LTD | Inde | 16398.93 | AMM_2021_11448 | 2027-07-31 |
| DOLUTEGRAVIR/LAMIVUDINE/TENOFOVIR 50mg+300mg+300mg Comprimé pelliculé B/30 | DOLUTEGRAVIR + LAMIVUDINE + TENOFOVIR | CIPLA QUALITY CHEMICAL INDUSTRIES LIMITED | Inde | 16398.93 | AMM_2021_11448 | 2027-07-31 |
| DOLUTEGRAVIR/LAMIVUDINE/TENOFOVIR 50mg+300mg+300mg Comprimé pelliculé B/90 | DOLUTEGRAVIR + LAMIVUDINE + TENOFOVIR | SUN PHARMACEUTICALS INDUSTRIES LIMITED | Inde | 16398.93 | AMM_2021_11448 | 2027-07-31 |
| EFFERALGAN 150mg Suppositoire B/10 | PARACETAMOL | UPSA SAS | France | 544.44 | 7530 | 2027-07-31 |
| EFFERALGAN 300mg Suppositoire B/10 | PARACETAMOL | UPSA SAS | France | 603.48 | 7534/09 | 2027-07-31 |
| EFFERALGAN 500mg Comprimé B/16 | PARACETAMOL | UPSA SAS | France | 662.52 | 7528/09 | 2027-07-31 |
| EFFERALGAN 80mg Suppositoire B/10 | PARACETAMOL | UPSA SAS | France | 505.08 | 7530/09 | 2027-07-31 |
| ENTEROGERMINA 2milliards/5mL Suspension buvable en flacon B/10 | SPORES DE BACILLUS CLAUSII POLYANTIBIO-RESISTANTES | SANOFI-AVENTIS SENEGAL | Italie | 1666.13 | 6055/07 | 2027-07-31 |
| FLUOMAC 150mg Gélule B/1 | FLUCONAZOLE | MACLEODS PHARMACEUTICAL LTD. | Inde | 249.26 | 6336/07 | 2027-07-31 |